Found: 12
Select item for more details and to access through your institution.
ADE Eval: An Evaluation of Text Processing Systems for Adverse Event Extraction from Drug Labels for Pharmacovigilance.
- Published in:
- Drug Safety, 2021, v. 44, n. 1, p. 83, doi. 10.1007/s40264-020-00996-3
- By:
- Publication type:
- Article
Efficacy and Safety of Bevacizumab Plus Oxaliplatin- or Irinotecan-Based Doublet Backbone Chemotherapy as the First-Line Treatment of Metastatic Colorectal Cancer: A Systematic Review and Meta-analysis.
- Published in:
- Drug Safety, 2021, v. 44, n. 1, p. 29, doi. 10.1007/s40264-020-00997-2
- By:
- Publication type:
- Article
Dissemination of Direct Healthcare Professional Communications on Medication Errors for Medicinal Products in the EU: An Explorative Study on Relevant Factors.
- Published in:
- Drug Safety, 2021, v. 44, n. 1, p. 73, doi. 10.1007/s40264-020-00995-4
- By:
- Publication type:
- Article
Introduction or Discontinuation of Additional Risk Minimisation Measures During the Life Cycle of Medicines in Europe.
- Published in:
- Drug Safety, 2021, v. 44, n. 1, p. 63, doi. 10.1007/s40264-020-00993-6
- By:
- Publication type:
- Article
Patterns of Benzodiazepine Use and Excess Risk of All-Cause Mortality in the Elderly: A Nationwide Cohort Study.
- Published in:
- Drug Safety, 2021, v. 44, n. 1, p. 53, doi. 10.1007/s40264-020-00992-7
- By:
- Publication type:
- Article
Understanding and Responding to Prescribing Patterns of Sodium Valproate-Containing Medicines in Pregnant Women and Women of Childbearing Age in Western Cape, South Africa.
- Published in:
- Drug Safety, 2021, v. 44, n. 1, p. 41, doi. 10.1007/s40264-020-00987-4
- By:
- Publication type:
- Article
Global Safety Database Summary of COVID-19-Related Drug Utilization-Safety Surveillance: A Sponsor's Perspective.
- Published in:
- Drug Safety, 2021, v. 44, n. 1, p. 95, doi. 10.1007/s40264-020-01035-x
- By:
- Publication type:
- Article
Frequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using the US Food and Drug Administration Adverse Event Reporting System.
- Published in:
- Drug Safety, 2021, v. 44, n. 1, p. 107, doi. 10.1007/s40264-020-01022-2
- By:
- Publication type:
- Article
How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Follow-up on the Use of Advanced Analytics for Clinical Quality Assurance: Bootstrap Resampling to Enhance Detection of Adverse Event Under-Reporting.
- Published in:
- Drug Safety, 2021, v. 44, n. 1, p. 121, doi. 10.1007/s40264-020-01011-5
- By:
- Publication type:
- Article
Effective Pharmacovigilance System Development: EFPIA-IPVG Consensus Recommendations.
- Published in:
- Drug Safety, 2021, v. 44, n. 1, p. 17, doi. 10.1007/s40264-020-01008-0
- By:
- Publication type:
- Article
Chances and Challenges of Registry-Based Pharmacovigilance in Multiple Sclerosis: Lessons Learnt from the Implementation of the Multicenter REGIMS Registry.
- Published in:
- Drug Safety, 2021, v. 44, n. 1, p. 7, doi. 10.1007/s40264-020-01007-1
- By:
- Publication type:
- Article